Dow Chemical Seeks U.S. High Court Review On Patents Under Teva
WASHINGTON, D.C. — Two chemical companies argue to the U.S. Supreme Court in an April 15 brief that an appellate court properly considered Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (135...To view the full article, register now.
Already a subscriber? Click here to view full article